Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

4.51 (USD) • At close September 19, 2024
Bedrijfsnaam Ironwood Pharmaceuticals, Inc.
Symbool IRWD
Munteenheid USD
Prijs 4.51
Beurswaarde 720,422,890
Dividendpercentage 0%
52-weken bereik 3.79 - 15.7
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Thomas A. McCourt
Website https://www.ironwoodpharma.com

An error occurred while fetching data.

Over Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States

Vergelijkbare Aandelen

Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

MYGN

28.29 USD

PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation

PRCT

82.79 USD

Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

20.84 USD

LumiraDx Limited logo

LumiraDx Limited

LMDX

0.016 USD

Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc.

FLGT

22.89 USD

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

4.81 USD

Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc.

RLAY

7.86 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)